PT - JOURNAL ARTICLE AU - Bisakh Bhattacharya AU - Rohit Kumar AU - Ved Prakash Meena AU - Manish Soneja AU - Saurabh Vig AU - Vandana Rastogi AU - Sushma Bhatnagar AU - Anant Mohan AU - Naveet Wig TI - SARS-CoV-2 RT-PCR profile in 298 Indian COVID-19 patients : a retrospective observational study AID - 10.1101/2020.06.19.20135905 DP - 2020 Jan 01 TA - medRxiv PG - 2020.06.19.20135905 4099 - http://medrxiv.org/content/early/2020/06/20/2020.06.19.20135905.short 4100 - http://medrxiv.org/content/early/2020/06/20/2020.06.19.20135905.full AB - Background Despite being in the 5th month of pandemic, knowledge with respect to viral dynamics, infectivity and RT-PCR positivity continues to evolve.Aim To analyse the SARS CoV-2 nucleic acid RT-PCR profiles in COVID-19 patients.Design It was a retrospective, observational study conducted at COVID facilities under AIIMS, New Delhi.Methods Patients admitted with laboratory confirmed COVID-19 were eligible for enrolment. Patients with incomplete details, or only single PCR tests were excluded. Data regarding demographic details, comorbidities, treatment received and results of SARS-CoV-2 RT-PCR performed on nasopharyngeal and oropharyngeal swabs, collected at different time points, was retrieved from the hospital records.Results 298 patients were included, majority were males (75·8%) with mean age of 39·07 years (0·6-88 years). The mean duration from symptom onset to first positive RT-PCR was 4·7 days (SD 3·67), while that of symptom onset to last positive test was 17·83 days (SD 6·22). Proportions of positive RT-PCR tests were 100%, 49%, 24%, 8·7% and 20·6% in the 1st, 2nd, 3rd, 4th & >4 weeks of illness. 12 symptomatic patients had prolonged positive test results even after 3 weeks of symptom onset. Age >= 60 years was associated with prolonged RT-PCR positivity (statistically significant).Conclusion This study showed that the average period of PCR positivity is more than 2 weeks in COVID-19 patients; elderly patients have prolonged duration of RT-PCR positivity and requires further follow up.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno funding requiredAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:institutitional ethical committeeAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is secure and with the invetigators. It will be shared only when required.